Co. designs, manufactures and sells a range of medical, surgical and diagnostic devices. Co.'s business units are: Oncology/Surgery, which provides a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the NanoKnife System, an alternative to thermal ablation; Vascular Interventions and Therapies, which supports the medical areas of thrombus management, Atherectomy, peripheral products and venous insufficiency; and Vascular Access, which includes a range of peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters and related accessories and supplies. The ANGO YTD return is shown above.
The YTD Return on the ANGO YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether ANGO YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ANGO YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|